After achieving optimal results, many patients transition to a maintenance protocol with less frequent dosing
Novo Nordisk says the Wegovy pill should be widely available starting in January
GLP-1 prescription growth reflects FDA approvals of newer, more effective agents like semaglutide and tirzepatide, demonstrated cardiovascular benefits in clinical trials, and expanded indications for both type 2 diabetes and chronic weight management
The research identifies six distinct types, each with its own presentation timeline, underlying mechanism, and treatment approach
You may end up paying a percentage of the total cost or a small copay, depending on your coverage
DSIP may be legally purchased in the UK when sold and used strictly for laboratory research purposes